What does CUSIP 007002108 represent in this 13F holders report?

CUSIP 007002108 is the security identifier for ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 used to aggregate holder disclosures.

How many institutions held ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in Q2 2023?

92 institutional investors reported ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 for Q2 2023. Use the holders table for investor-level position and value details.

Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 9,599,852
Total 13F shares: 37,121,626
Share change: -3,027,451
Total reported value: $90,180,708
Put/Call ratio: 122%
Price per share: $2.43
Number of holders: 92
Value change: -$28,161,740
Number of buys: 44
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 007002108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	78%	7,447,140	$42,895,526	—	31 Mar 2023	13F
RTW INVESTMENTS, LP	13F	Company	44%	4,241,472	$24,430,879	—	31 Mar 2023	13F
EcoR1 Capital, LLC	13F	Company	37%	3,560,700	$20,509,632	—	31 Mar 2023	13F
COWEN AND COMPANY, LLC	13F	Company	33%	3,143,608	$18,107,182	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	26%	2,536,802	$14,611,981	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	26%	2,520,000	$14,515,200	—	31 Mar 2023	13F
Carlyle Group Inc.	13F	Company	22%	2,115,385	$12,163,464	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	18%	1,690,469	$9,737,102	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	17%	1,639,878	$9,445,698	—	31 Mar 2023	13F
Polar Capital Holdings Plc	13F	Company	13%	1,263,825	$7,279,632	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	13%	1,230,763	$6,525,128	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	8.3%	797,054	$4,591,031	—	31 Mar 2023	13F
JOHNSON & JOHNSON	13F	Company	7.6%	728,944	$4,198,717	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	6.3%	606,189	$3,491,648	—	31 Mar 2023	13F
Decheng Capital Management III (Cayman), LLC	13F	Company	6%	580,000	$3,340,800	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	5.9%	564,457	$3,251,272	—	31 Mar 2023	13F
Foresite Capital Management V, LLC	13F	Company	5.8%	558,636	$3,217,743	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	5.8%	558,367	$3,216,362	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.2%	501,825	$2,890,512	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.3%	315,800	$1,819,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	3.3%	312,977	$1,802,747	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2.9%	276,763	$1,594,155	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	2.7%	262,432	$1,511,609	—	31 Mar 2023	13F
BAILLIE GIFFORD & CO	13F	Company	1.9%	181,626	$1,046,166	—	31 Mar 2023	13F
Russell Investments Group, Ltd.	13F	Company	1.8%	174,710	$1,006,328	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.8%	170,876	$984,000	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	1.6%	156,833	$903,359	—	31 Mar 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	1.6%	154,708	$889,571	—	31 Mar 2023	13F
Ergoteles LLC	13F	Company	1.4%	132,197	$761,455	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.2%	112,104	$645,719	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	1%	100,040	$576,230	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	99,306	$572,002	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.99%	94,685	$545,000	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.96%	92,296	$531,625	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.85%	81,170	$467,539	—	31 Mar 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.69%	66,611	$383,680	—	31 Mar 2023	13F
Granite Point Capital Management, L.P.	13F	Company	0.68%	65,729	$378,599	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.51%	49,435	$284,746	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.5%	47,618	$274,000	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.46%	44,605	$256,925	—	31 Mar 2023	13F
Verition Fund Management LLC	13F	Company	0.45%	42,910	$247,162	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.44%	42,331	$244,000	—	31 Mar 2023	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.44%	42,232	$243,000	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.43%	41,600	$239,616	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.43%	41,300	$237,888	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.42%	40,329	$232,295	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.4%	38,252	$220,331	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.34%	32,960	$189,850	—	31 Mar 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.34%	32,279	$185,927	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.33%	31,414	$180,945	—	31 Mar 2023	13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2023

As of 30 Jun 2023, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,121,626 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, BlackRock Inc., Carlyle Group Inc., VANGUARD GROUP INC, DEUTSCHE BANK AG\, and DAFNA Capital Management LLC. This page lists 92 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

105

Q2 2023 holders

Holder diff

-13

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.